August 29, 2022

[Address block here]

Dear Speaker Pelosi, Leaders McCarthy, Schumer, and McConnell, Chairs Pallone and Murray, and Ranking Members Rogers and Burr:

We write on behalf of a diverse group of stakeholders, representing [categories of signatory will be listed here]. We wish to express appreciation of your continuing efforts to deliver vital funding to the Food and Drug Administration (FDA) through user fee reauthorization legislation emerging from the House Energy and Commerce Committee and the Senate Health, Education, Labor and Pensions (HELP) Committee. We urge that as you work to reconcile these bills, you address urgent public health challenges by maintaining critical protections in the FDA Safety and Landmark Advancements Act (FDASLA), S. 4348.

This legislation includes safeguards that will help ensure Americans have access to safe dietary supplements, accurate tests used in clinical medicine, a safe and reliable supply of infant formula and other essential medical foods, food packaging free of harmful PFAS chemicals, safe cosmetics, and affordable and timely access to effective and safe medicines tested in diverse populations. [open to considering others provisions proposed by additional groups]

These necessary, bipartisan policies reflect years of continuous engagement and thoughtful collaboration among committee and congressional leaders, the executive branch, and the public stakeholder community. Our organizations deeply appreciate the careful balance the Senate HELP Committee struck in the legislation it advanced to markup on June 14th, 2022.

We urge you not to forgo this key opportunity to advance long-awaited solutions for the American public. While some provisions could be strengthened still further from the Senate version, we express our continued support for the meaningful reforms contained in the bill, and hope that Congressional and committee leadership remain committed to negotiating these protections as you advance this important legislation.

Signed,